SPRY2 and hepatocellular carcinoma: MiR-21 upregulation in HCC promotes oncogenic hallmarks by targeting PTEN, PDCD4, RECK, ARHGAP24, TIMP3, SPAY1/Spry1, and SPRY2/Spry2, as reviewed by Wang X et al. [60].